Codiak BioSciences, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Codiak BioSciences, Inc. had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $14.67 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2022-11-03
- 2022-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.67M.
- 2022-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15.56M.
- 2022-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16.47M.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17.39M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-09-30 | $14.67M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $15.56M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $16.47M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $17.39M 10-K · filed 2022-03-10 |
| 2021-09-30 | $18.30M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $19.25M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $20.21M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $21.18M 10-K · filed 2021-03-17 |
| 2020-09-30 | $22.16M 10-Q · filed 2020-11-19 |